
Dual-Targeted CAR T Cell Therapy Shows Promise in Slowing Aggressive Brain Tumor Progression
In a groundbreaking leap forward for brain cancer treatment, researchers from the University of Pennsylvania have unveiled promising results from a novel dual-target CAR T cell therapy aimed at recurrent glioblastoma (GBM), one of the most aggressive and …